Product Highlights Peptide: Retatrutide (LY3437943) Strength: 30mg per vial Category: Triple GIP, GLP1 & Glucagon Receptor Agonist Form: Lyophilized (freeze-dried) peptide powder Administration: Reconstituted for subcutaneous injection in research settings Quality: High-purity research-grade peptide What Is Retatrutide Made Of
A University of Mississippi-led study found that insurers would have to offer more services than just the medication to produce long-term cost savings
They will walk you through a screening process: your medical history, blood tests, a physical exam, and a consent form
Results from our previous study revealed that GEP44 binds to GLP-1R, Y1-R, and Y2-R 16
Tirzepatide (Mounjaro, Zepbound) targets two pathways (GLP-1 and GIP), producing greater weight loss in head-to-head studiesroughly 20% body weight loss on tirzepatide vs 15% on semaglutide
Retatrutide is an unlicensed investigational triple GLP-1, GIP, and glucagon receptor agonist not yet approved by the MHRA or EMA